Antibody News and Research

RSS

An antibody is a blood protein that is produced in response to and counteracts an antigen. Antibodies are produced in response to disease and help the body fight against the particular disease. In this way, antibodies help the body develop an immunity to disease.

Mitochondrial RNA May Explain How Tumors Become Resistant to Immunotherapy

Research highlights mitochondrial RNA's influence on interferon signaling, linking chronic exposure to tumor growth and offering new avenues for immunotherapy.

22 Sep 2026

Infected Macrophages Release Inflammatory Signals That Accelerate Surrounding Lung Infection

In the sickest COVID-19 patients, the SARS-CoV-2 virus doesn't just cause severe damage by directly infecting airway cells.

22 Sep 2026

Researchers Discover Dual Immune Mechanisms Controlling Latent HIV Vectors

There is no cure for HIV. While scientists have made considerable progress in controlling the infection, patients still must take daily antiretroviral medication for the rest of their lives.

18 Sep 2026

New Mathematical Models Track Surface Protein Interactions to Map Evolutionary Terrains

When a virus mutates, the world usually finds out the hard way. Variants of influenza and SARS‑CoV‑2 can slip past vaccines and antibody drugs before scientists fully understand what has changed.

15 Sep 2026

Advanced Diagnostic Technologies Target Inaccessible Plasma Cells Housed inside Bones

For decades, immunologists have known that the body's most durable defenses depend on plasma cells, the antibody-producing cells responsible for long-term immune memory.

15 Sep 2026

Icosagen Develops Manufacturing-Ready CHO Cell Line for EPOK Therapeutics' Complex Tetravalent Antibody-Like Protein

Icosagen, a private European protein therapeutics CRDMO, and EPOK Therapeutics Inc., a pre-clinical-stage biopharmaceutical company, based in Toronto, Canada, today announced the successful completion of a development project for EPOK's novel antibody EPRA-0322.

From Icosagen 15 Sep 2026

New Platform Promises Rapid Vaccine Monitoring and Biomarker Discovery for Emerging Pathogens

A research team comprising Associate Professor FUNAKOSHI Yohei, Associate Professor YAKUSHIJIN Kimikazu, Professor MINAMI Hironobu, and Associate Professor OHJI Goh of Kobe University, together with graduate student MASUDA Genki, then-graduate student IIZUMI Shunsuke, Associate Professor OHUE Masahito, and colleagues at the Institute of Science Tokyo, has developed a new analysis method, LM-QASAS.

9 Sep 2026

Research Maps Complex Molecular Rules Governing Specialized Tumor Immunity

For decades, natural killer (NK) cells have been classified into two main groups based on surface markers: one specialized for cytokine production and the other for direct killing.

7 Sep 2026

Bacterial Protein Fragment Disrupts Cell Quality Systems Causing Tissue Scarring

A bacterial protein fragment called corisin drives the process of pulmonary fibrosis by infiltrating and disrupting the cell's quality-control system, researchers at the University of Illinois Urbana-Champaign and Mie University in Japan found in a new study.

1 Sep 2026

Single Line T Cell Immunity Fails Maintaining Permanent Zika Protections

CA-Zika virus has been spreading for decades, but it first grabbed worldwide headlines in 2016. That February, with an outbreak sweeping the Americas, the World Health Organization (WHO) declared the surge in Zika-linked birth defects a "public health emergency of international concern"-a designation which lasted until that November.

31 Aug 2026

Researchers Track Harmful Post COVID Autoantibodies to Specific B Cells

When the immune system encounters a virus, it produces antibodies designed to recognize and eliminate the invader.

31 Aug 2026

Colorectal Cancer and Nerve Damage: A Hidden Link Uncovered in Mice and Primates

Colorectal tumors trigger inflammatory nerve damage, suggesting cancer itself may be a risk factor for neuropathy in survivors, independent of treatments.

27 Aug 2026

New Model Accelerates Design of Protein Degrader Drugs

A team of Weill Cornell Medicine investigators has developed a computer model that will help scientists more efficiently develop protein-destroying therapies, a newer type of treatment that is particularly promising for cancer.

27 Aug 2026

Advanced Peptides Overcome Human Biological Barriers in New Cancer Medicine

Influencers across TikTok and the internet have been touting peptides as a beauty and health cure-all, with some claiming they can de-age you or significantly transform your appearance.

25 Aug 2026

Antibodies for Visualizing Cell Identity and Tumor Architecture

Whether you are characterizing cell state transitions, assessing organelle integrity, or building a multiplex immunofluorescence (IF) assay, you need reliable structural markers for your imaging.

From Antibodies Incorporated 21 Aug 2026

AI Models Zero In on Antibody Binding Regions to Improve Drug Target Predictions

Focusing on complementarity-determining regions in antibody models leads to better binding affinity predictions, potentially accelerating treatment discovery.

20 Aug 2026

Locally Activated Skull T Cells Halt Glioblastoma Growth in Mice

Researchers at Washington University School of Medicine in St. Louis have discovered lymph node-like structures in the skull bone marrow of mice for the first time and demonstrated that they act as rapid first responders against brain cancer before distant lymph nodes get the signal that abnormal cells are present.

20 Aug 2026

Antibody News and Research

Further Reading

Mitochondrial RNA May Explain How Tumors Become Resistant to Immunotherapy

Infected Macrophages Release Inflammatory Signals That Accelerate Surrounding Lung Infection

Researchers Discover Dual Immune Mechanisms Controlling Latent HIV Vectors

New Mathematical Models Track Surface Protein Interactions to Map Evolutionary Terrains

Advanced Diagnostic Technologies Target Inaccessible Plasma Cells Housed inside Bones

Icosagen Develops Manufacturing-Ready CHO Cell Line for EPOK Therapeutics' Complex Tetravalent Antibody-Like Protein

New Platform Promises Rapid Vaccine Monitoring and Biomarker Discovery for Emerging Pathogens

Research Maps Complex Molecular Rules Governing Specialized Tumor Immunity

Bacterial Protein Fragment Disrupts Cell Quality Systems Causing Tissue Scarring

Single Line T Cell Immunity Fails Maintaining Permanent Zika Protections

Researchers Track Harmful Post COVID Autoantibodies to Specific B Cells

Colorectal Cancer and Nerve Damage: A Hidden Link Uncovered in Mice and Primates

New Model Accelerates Design of Protein Degrader Drugs

Advanced Peptides Overcome Human Biological Barriers in New Cancer Medicine

Antibodies for Visualizing Cell Identity and Tumor Architecture

AI Models Zero In on Antibody Binding Regions to Improve Drug Target Predictions

Locally Activated Skull T Cells Halt Glioblastoma Growth in Mice

Basel Study Challenges Long-Held Assumptions About Coronin Proteins

Mapping Functional Polyprotein Cleavage Sites Solves Post Infection Testing Dilemmas

Novel Approach Provides a Flexible Foundation for Measuring Coronavirus Protease Activity

Antibodies eBook

The Future of Vision Restoration With ReVision Implant

How a Single List Is Changing Visibility for Women in Science

How Avatar Medical's 3D Technology Is Transforming How We Visualize the Human Body

RecentIndustryFocuses

Editorial Focus eBook - Biopharmaceuticals (2nd edition)

Improving Cell Culture Efficiency with Image-Guided Automation

Improving Scalability in Organoid Research

Cosmetic Formulation and Manufacturing

Latest in Genomics